Are you Dr. Markham?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 40 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
615 N Wolfe St
Baltimore, MD 21205Phone+1 410-955-9601Fax+1 410-614-8263- Is this information wrong?
Summary
- Dr. Richard Markham, MD is an infectious disease specialist in Baltimore, Maryland. He is currently licensed to practice medicine in Maryland.
Education & Training
- Brigham and Women's HospitalResidency, Internal Medicine, 1977 - 1979
- Jacobi Medical Center/Albert Einstein College of MedicineResidency, Internal Medicine, 1973 - 1975
- Albert Einstein College of MedicineClass of 1972
Certifications & Licensure
- MD State Medical License 1976 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 16 citationsAnti-IL-10-mediated Enhancement of Antitumor Efficacy of a Dendritic Cell-targeting MIP3α-gp100 Vaccine in the B16F10 Mouse Melanoma Model Is Dependent on Type I Inter...James T. Gordy, Kun Luo, Brian Francica, Charles G. Drake, Richard B. Markham> ;Journal of Immunotherapy. 2018 May 1
- 7 citationsExtended protection capabilities of an immature dendritic-cell targeting malaria sporozoite vaccine.Kun Luo, Fidel Zavala, James T. Gordy, Hong Zhang, Richard B. Markham> ;Vaccine. 2017 Apr 25
- 20 citationsInhibition of Vpx-Mediated SAMHD1 and Vpr-Mediated Host Helicase Transcription Factor Degradation by Selective Disruption of Viral CRL4 (DCAF1) E3 Ubiquitin Ligase Ass...Hong Wang, Haoran Guo, Jiaming Su, Yajuan Rui, Wenwen Zheng, Wenying Gao, Wenyan Zhang, Zhaolong Li, Guanchen Liu, Richard B. Markham, Wei Wei, Xiao Fang Yu> ;Journal of Virology. 2017 Apr 13
- Join now to see all
Grant Support
- Use Of Clonal Genotyping To Predict Resistance Development In Art-Naive IDUNational Institute On Drug Abuse2008–2012
- Effect Of Cocaine And LTR Polymorphism On HIV-1 PathogenesisNational Institute On Drug Abuse2008–2012
- Training: Molecular &Cellular Bases Of Infectious DiseasesNational Institute Of Allergy And Infectious Diseases2010–2011
- Roche 454 Genome Sequencer FlxNational Center For Research Resources2010
- Development Of Transformed Lactobacilli As A MicrobicideNational Institute Of Allergy And Infectious Diseases2009–2010
- Development Of A Malaria DNA Vaccine With Enchanced ImmunogenicityNational Institute Of Allergy And Infectious Diseases2008–2009
- Anti-Icam-I Scfv From Lactobacilli As A MicrobicideNational Institute Of Allergy And Infectious Diseases2004–2007
- Anti-Icam-1 Scfv From Lactobacilli As A MicrobicideNational Institute Of Allergy And Infectious Diseases2003–2004
- Drug Abuse And Resistance To Antiretroviral TherapyNational Institute On Drug Abuse2000–2004
- Acquired Immunodeficiency Syndrome ReviewNational Institute Of Allergy And Infectious Diseases2001–2002
- Impact Of Recombination In HIV-1 On Intrahost EvolutionNational Institute Of General Medical Sciences1999–2002
- HIV 1 Immune Activation And Pathogenesis In Drug UsersNational Institute On Drug Abuse1995–1998
- Genetic Determinants Of HIV Infection Of IV Drug UsersNational Institute On Drug Abuse1995–1998
- Model For AIDS TherapyNational Institute Of Allergy And Infectious Diseases1989–1993
- Core--Scid-Hu MouseNational Institute Of Allergy And Infectious Diseases1989–1993
- T Cell Immunity To Extracellular BacteriaNational Institute Of Allergy And Infectious Diseases1989–1991
- T Cell Killing Of Extracellular BacteriaNational Institute Of Allergy And Infectious Diseases1985–1987